Molecular Playground/Targeting Peptide: Difference between revisions

Newer edit →

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Solfiell

Revision as of 20:17, 5 May 2010 view source David Solfiell (talk \| contribs) 21 edits New page: <applet scene='Molecular_Playground/David's_temporary_page/Temp_scene/1' load='1l5g' size='300' frame='true' align='right' caption='The RGD peptide is a popular peptide targeting motif use...		Revision as of 20:30, 5 May 2010 view source David Solfiell (talk \| contribs) 21 edits No edit summary Newer edit →
Line 1:		Line 1:
	<applet scene='Molecular_Playground/David's_temporary_page/Temp_scene/1' load='1l5g' size='300' frame='true' align='right' caption='The RGD peptide is a popular peptide targeting motif used in experimental, nanoscale drug delivery vehicles (such as liposomes, micelles, nanoparticles, etc.) The RGD peptide binds specifically with cell adhesion molecules on the cell surface. Upregulation/overexpression of the cell surface markers on certain kinds of cancer ~~lead~~ to selective accumulation of nanomaterial drug carriers within cancerous tissues.' />		<applet scene='Molecular_Playground/David's_temporary_page/Temp_scene/1' load='1l5g' size='300' frame='true' align='right' caption='The RGD peptide is a popular peptide targeting motif used in experimental, nanoscale drug delivery vehicles (such as liposomes, micelles, nanoparticles, etc.) The RGD peptide binds specifically with cell adhesion molecules on the cell surface. Upregulation/overexpression of the cell surface markers on certain kinds of cancer leads to selective accumulation of nanomaterial drug carriers within cancerous tissues. Shown is the cyclic analogue of the RGD peptide complexed with alpha 5 Integrin.' />